Clinical Trial Update: Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia [NA]

View source ↗

Summary

This document reports a completed pilot trial evaluating naltrexone for obesity in women with schizophrenia; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Obesity, Schizophrenia | NA | Status: COMPLETED | Results posted: 2016-10-06